JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katz, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katz, N.
Related Collections
Right arrow Anesthesia
Right arrowRelated Article

J Thorac Cardiovasc Surg 2004;127:605
© 2004 The American Association for Thoracic Surgery

Letter to the editor

Reporting of clinical trials of analgesia

Nathaniel Katz, MD, MS

300 Elliot St, Newton, MA 02464, USA

The first 20% of the full text of this article appears below.

To the Editor:

Ott and colleagues,1 and the editorial staff of the Journal,deserve much credit for carrying out and publishing a study on the use of cyclooxygenase 2 inhibitors for postoperative pain after coronary artery bypass grafting. However, the study report is beset with serious deficiencies in the presentation of the study results, which should be noted to avoid similar deficiencies in what I hope will be future publications of studies on postoperative pain relief.

Ott and colleagues1 commendably sought to provide a risk-benefit assessment of the use of parecoxib and valdecoxib in the post–coronary artery bypass grafting setting by reporting on both the degree of pain relief and differences in adverse effects associated with the study drugs relative to the control group. The first issue is the choice of primary outcome measure: amount of reduction in morphine . . . [Full Text of this Article]


Related Article

Reply to the Editor
Dennis T. Mangano
J. Thorac. Cardiovasc. Surg. 2004 127: 606. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Br J AnaesthHome page
M. W. Khalil, A. Chaterjee, G. MacBryde, P. K. Sarkar, and R. R. D. Marks
Single dose parecoxib significantly improves ventilatory function in early extubation coronary artery bypass surgery: a prospective randomized double blind placebo controlled trial
Br. J. Anaesth., February 1, 2006; 96(2): 171 - 178.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.